MURPHY ANDREW J 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Oct 31, 2025
Insider Transaction Report
Form 4
MURPHY ANDREW J
EVP Research
Transactions
- Tax Payment
Common Stock
2025-10-29$648.82/sh−32,490$21,080,162→ 51,584 total - Gift
Common Stock
2025-10-30−1,538→ 50,046 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-10-29−35,000→ 0 totalExercise: $555.67Exp: 2025-12-16→ Common Stock (35,000 underlying) - Exercise/Conversion
Common Stock
2025-10-29$555.67/sh+35,000$19,448,450→ 84,074 total
Holdings
- 4,370(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]The stock option award vested in four equal annual installments, commencing one year after the date of grant.